Minerva Neurosciences, Inc. (NERV) return on equity (ROE)

Return on equity · fiscal 2021
-625.7%

Minerva Neurosciences, Inc. (NERV) earned a return on equity of -625.7% in fiscal 2021 (the year ended December 31, 2021). That is 629.4 percentage points lower than the 3.7% of fiscal 2020. Figures as of 17 Nov 2026, 21:35 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Return on equity, fiscal 2021
-625.7%
Change on fiscal 2020
−629.4 pts
Highest on record
3.7%fiscal 2020
Lowest on record
-625.7%fiscal 2021
Fiscal years on record
82014–2021

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.

Minerva Neurosciences, Inc. return on equity (ROE), in more detail

Across the 8 fiscal years on record (2014–2021), the highest was 3.7% in fiscal 2020 and the lowest -625.7% in fiscal 2021. The fiscal 2021 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is -49.0%.

History · 8 fiscal years

Return on equity by fiscal year

Minerva Neurosciences, Inc. return on equity (ROE), year by year

Minerva Neurosciences, Inc. (NERV) return on equity (ROE) by fiscal year
Fiscal yearReturn on equityChangeYear ended
2021-625.7% 629.4 pts down
20203.7% 263.5 pts up
2019-259.8% 204.3 pts down
2018-55.6% 31.6 pts down
2017-24.0% 5.3 pts up
2016-29.3% 19.7 pts up
2015-49.0% 61.5 pts up
2014-110.5%—

Change is on the fiscal year before, in percentage points; a dash means that year is not on record. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

How to read it

It is the profit earned on the owners' capital — above about 15% is strong, though heavy debt or large buybacks can inflate it.

More on NERV

Minerva Neurosciences, Inc., figure by figure

Minerva Neurosciences, Inc. (NERV) overview: price, valuation and scorecard

Minerva Neurosciences, Inc. return on equity (ROE): questions and answers

What is Minerva Neurosciences, Inc.'s return on equity?

Minerva Neurosciences, Inc. (NERV) earned a return on equity of -625.7% in fiscal 2021 (the year ended December 31, 2021). That is 629.4 percentage points lower than the 3.7% of fiscal 2020.

Is Minerva Neurosciences, Inc.'s return on equity high or low compared with its own history?

The fiscal 2021 figure is no higher than in any of the 7 earlier fiscal years on record, whose median is -49.0%.

What are the highest and lowest return on equity figures on record for Minerva Neurosciences, Inc.?

Across the 8 fiscal years on record (2014–2021), the highest was 3.7% in fiscal 2020 and the lowest -625.7% in fiscal 2021.

How is Minerva Neurosciences, Inc.'s return on equity calculated?

Return on equity is net income divided by shareholders' equity at the fiscal year-end; it is left blank when equity is negative.

Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Minerva Neurosciences, Inc. (NERV) return on equity (ROE)”, data as of 17 November 2026. https://funkfolio.com/stock/NERV/roe

Underlying data: the company's filings with the SEC and Yahoo Finance.